(Q28571242)

31 January 2017

title

Sodium excretion in response to vasopressin and selective vasopressin receptor antagonists (English)

1 reference

31 January 2017

0 references

Julie Perucca

1

1 reference

31 January 2017

Daniel G. Bichet

2

1 reference

31 January 2017

Pascale Bardoux

3

1 reference

31 January 2017

Nadine Bouby

4

1 reference

31 January 2017

Lise Bankir

5

1 reference

31 January 2017

publication date

1 September 2008

1 reference

Journal of the American Society of Nephrology

31 January 2017

published in

1 reference

31 January 2017

volume

19

1 reference

31 January 2017

issue

9

1 reference

31 January 2017

page(s)

1721–1731

1 reference

Chronic V2 vasopressin receptor stimulation increases basal blood pressure and exacerbates deoxycorticosterone acetate-salt hypertension

31 January 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518442

Vasopressin does not effect hypertension caused by long-term nitric oxide inhibition

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518442

Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonist

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518442

Characterization of a novel aquaretic agent, OPC-31260, as an orally effective, nonpeptide vasopressin V2 receptor antagonist

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518442

Downregulation of vasopressin V2 receptor promoter activity via V1a receptor pathway

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518442

29 September 2017

Vasopressin antagonists

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518442

V1a vasopressin receptors maintain normal blood pressure by regulating circulating blood volume and baroreflex sensitivity.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518442

Functional and pharmacological characterization of the first specific agonist and antagonist for the V1b receptor in mammals

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518442

Evidence in man that urinary electrolyte loss induced by pitressin is a function of water retention

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518442

Abnormal regulation of ENaC: syndromes of salt retention and salt wasting by the collecting duct

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518442

An overview of SR121463, a selective non-peptide vasopressin V(2) receptor antagonist

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518442

Antidiuretic action of vasopressin: quantitative aspects and interaction between V1a and V2 receptor-mediated effects

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518442

Biochemical and pharmacological properties of SR 49059, a new, potent, nonpeptide antagonist of rat and human vasopressin V1a receptors

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518442

Hormonal signaling and regulation of salt and water transport in the collecting duct

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518442

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518442

Renal prostaglandin synthesis. Sites of production and specific actions of prostaglandins

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518442

Segmental synthesis and actions of prostaglandins along the nephron

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518442

Human platelet fraction arginine-vasopressin. Potential physiological role

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518442

Renal medullary circulation: hormonal control

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518442

Effect of vasopressin on sodium excretion and plasma antinatriferic activity in the dog.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518442

The regulation of vasopressin function in health and disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518442

Prostaglandin synthesis inhibition and the action of vasopressin: studies in man and rat

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518442

OPC-41061, a highly potent human vasopressin V2-receptor antagonist: pharmacological profile and aquaretic effect by single and multiple oral dosing in rats.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518442

Renal tubular and vascular urea transporters: influence of antidiuretic hormone on messenger RNA expression in Brattleboro rats.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518442

Low urine flow reduces the capacity to excrete a sodium load in humans.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518442

1-desamino-8-D-arginine vasopressin (DDAVP) as an agonist on V1b vasopressin receptor

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518442

Disparate expression of the AVP gene in Sabra hypertension-prone and hypertension-resistant rats.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518442

The influence of a single dose of vasopressin analogs on human renal potassium excretion.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518442

Natrriuresis produced by vasopressin or hemorrhage during water diuresis in the dog.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518442

Interactions between ADH and prostaglandins in isolated erythrocyte-perfused rat kidney

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518442

Development of a test to evaluate the transtubular potassium concentration gradient in the cortical collecting duct in vivo

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518442

Ethnic differences in urine concentration: possible relationship to blood pressure.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518442

Vasopressin, Urine Concentration, and Hypertension: A New Perspective on an Old Story

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518442

Vasopressin antagonists in polycystic kidney disease

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518442

Vasopressin-V2 receptor stimulation reduces sodium excretion in healthy humans

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518442

Pharmacodynamic effects of a nonpeptide antidiuretic hormone V2 antagonist in cirrhotic patients with ascites

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518442

Chronic exposure to vasopressin upregulates ENaC and sodium transport in the rat renal collecting duct and lung

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518442

Level of hydration and renal function in healthy humans.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518442

Difference in solute excretion during correction of hyponatremic patients with cirrhosis or syndrome of inappropriate secretion of antidiuretic hormone by oral vasopressin V2 receptor antagonist VPA-985.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518442

Effects of the nonpeptide V(1) vasopressin receptor antagonist SR49059 in hypertensive patients.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518442

Mechanism of vasopressin natriuresis in the dog: role of vasopressin receptors and prostaglandins.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518442

In vivo diuretic effect of a new non-peptide arginine vasopressin antagonist, OPC-31260, in conscious rats.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518442

Aquaretic effects of the nonpeptide V2 antagonist OPC-31260 in hydropenic humans.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518442

Role of urinary arginine vasopressin in the sodium excretion in patients with chronic renal failure

27 November 2018

1 reference

12 December 2020

Vasopressin-stimulated release of atriopeptin: endocrine antagonists in fluid homeostasis

1 reference

12 December 2020

Interactive computerized microscopy as a tool for quantifying vascular remodelling effects of diabetes and V1a receptor antagonist SR 49059 on rat mesenteric arterial bed

1 reference

12 December 2020

Acute renal response to the non-peptide vasopressin V2-receptor antagonist SR 121463B in anesthetized rats

1 reference

12 December 2020

Functional evidence for an apical V1 receptor in rabbit cortical collecting duct

1 reference

12 December 2020

Vasopressin V2 receptor antagonists

1 reference

12 December 2020

Cell Ca2+ response to luminal vasopressin in cortical collecting tubule principal cells

1 reference

12 December 2020

[To concentrate the urine or to excrete sodium: 2 sometimes contradictory requirements]

1 reference

12 December 2020

Aquaretic and hormonal effects of a vasopressin V(2) receptor antagonist after acute and long-term treatment in rats

1 reference

12 December 2020

Effect of ADH on rubidium transport in isolated perfused rat cortical collecting tubules

1 reference

12 December 2020

Contribution of vasopressin to progression of chronic renal failure: study in Brattleboro rats

1 reference

12 December 2020

Natriuretic response of the rat to plasma concentrations of arginine vasopressin within the physiological range

1 reference

12 December 2020

Role of arginine vasopressin in medullary thick ascending limb on maximal urinary concentration

1 reference

12 December 2020

Impaired urinary flow rate during the day: a new factor possibly involved in hypertension and in the lack of nocturnal dipping

1 reference

12 December 2020

Role of volume status in vasopressin-induced natriuresis: studies in Brattleboro rats

1 reference

12 December 2020

Antidiuretic effect of subnormal levels of arginine vasopressin in normal humans

1 reference

12 December 2020

Natriuresis induced by arginine vasopressin infusion in sheep

1 reference

12 December 2020

Long-term aquaretic efficacy of a selective nonpeptide V(2)-vasopressin receptor antagonist, SR121463, in cirrhotic rats

1 reference

12 December 2020

Influence of ADH on renal potassium handling: a micropuncture and microperfusion study

1 reference

12 December 2020

Autoradiographic localization of vasopressin V1a receptors in the rat kidney using [3H]-SR 49059

1 reference

12 December 2020

Flow dependence of K+ secretion in cortical distal tubules of the rat

1 reference

12 December 2020

The effect of vasopressin and oxytocin on glomerular filtration rate in the conscious rat: contribution to the natriuretic response

1 reference

12 December 2020